DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line

Charles River Laboratories Slashes FY24 Outlook - Update

RTTNews | 384天前

Charles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) reaffirmed its adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2024.

RTTNews | 474天前

Charles River Laboratories Narrows FY23 Outlook Range; Q3 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) narrowed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance range for the full-year 2023.

RTTNews | 657天前

Charles River Labs Boosts FY23 Outlook As Q2 Results Top Estimates

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) raised its adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2023, to reflect the strong first-quarter financial performance and expectations for the remainder of the year that are largely consistent with its initial outlook.

RTTNews | 838天前

Charles River Labs Slashes FY22 Outlook; Q2 Adj. EPS Tops Estimates, Revenues Miss

While reporting financial results for the second quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) slashed its earnings, adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2022, due primarily to headwinds associated with the CDMO business, foreign exchange, and interest expense due to the rising interest rate environment.

RTTNews | 1119天前

DURECT Appoints Timothy Papp As New CFO

Biopharmaceutical company DURECT Corp. (DRRX) announced Tuesday the appointment of Timothy Papp as its Chief Financial Officer. Papp brings over 25 years of corporate finance experience to DURECT, including 15 years in the Biopharma sector.

RTTNews | 1148天前

French Consumer Sentiment Weakest Since 2023

France's consumer confidence weakened to the lowest level since October 2023 largely due to the weaker outlook for standard of living and the fall in saving intentions. The consumer sentiment index edged down to 87 in August from 88 in July. This was the lowest reading since October 2023 and remained below its long-term average of 100.

RTTNews | 1小时7分钟前

European Shares Decline Amid French Uncertainty

European shares traded lower on Tuesday, with Fed independence fears and French political risks keeping investors on edge.

RTTNews | 1小时28分钟前

EURUSD	1.16467	GBPUSD	1.34804	AUDUSD	0.64867
USDJPY	147.577	USDCAD	1.3847	USDCHF	0.80572